Cargando…
Targeting GRP75 Improves HSP90 Inhibitor Efficacy by Enhancing p53-Mediated Apoptosis in Hepatocellular Carcinoma
Heat shock protein 90 (HSP90) inhibitors are potential drugs for cancer therapy. The inhibition of HSP90 on cancer cell growth largely through degrading client proteins, like Akt and p53, therefore, triggering cancer cell apoptosis. Here, we show that the HSP90 inhibitor 17-AAG can induce the expres...
Autores principales: | Guo, Weiwei, Yan, Lichong, Yang, Ling, Liu, Xiaoyu, E, Qiukai, Gao, Peiye, Ye, Xiaofei, Liu, Wen, Zuo, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894982/ https://www.ncbi.nlm.nih.gov/pubmed/24465691 http://dx.doi.org/10.1371/journal.pone.0085766 |
Ejemplares similares
-
Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
por: Park, Hye-Kyung, et al.
Publicado: (2020) -
Exploring the Functional Complementation between Grp94 and Hsp90
por: Maharaj, Kevin A., et al.
Publicado: (2016) -
Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9
por: Rozenberg, Perri, et al.
Publicado: (2018) -
Upregulation of Phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in Acquired Middle Ear Cholesteatoma Growth
por: Ho, Kuen Yao, et al.
Publicado: (2013) -
Circumventing HSP90 inhibitors via apoptosis block
por: Fennell, Dean A., et al.
Publicado: (2015)